Noraker
FranceFDA applicant, unverified FDA FEI 3033809758
- Devices
- 28
- Registrations
- FDA
- FDA recalls
- 0
At a glance
Market reach
- United States
- FDA FEI
What Noraker makes
Noraker manufactures GlassBone Granules, a bone graft substitute designed for orthopedic and maxillofacial applications to promote bone regeneration and healing in surgical procedures.
The company’s portfolio is regulated under FDA Class II devices and requires 510(k) clearance. GlassBone Granules are listed in the FDA’s 510(k) registry. Noraker is based in the United States.
Catalogue
Search and filter all 28 devicesCompany details
- FDA FEI number
- 3033809758
- DUNS number
- 279959048
- Address
- 60 avenue Rockefeller, LYON Auvergne-Rhone-Alpes
Frequently asked questions
How many devices does Noraker have in the registry?
The registry currently lists 28 devices for Noraker. Devices recorded under merged duplicate company entries are counted once.
Which registries list Noraker's devices?
Among its 28 most recently registered devices, Noraker has devices listed in FDA 510(k) (1 device) and FDA GUDID (27 devices). A device can be listed in more than one registry, so these counts overlap.
What risk classes do Noraker's devices fall under?
Among its 28 most recently registered devices, the classes recorded for Noraker's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Noraker in the registry?
The most recently registered devices listed for Noraker include GlassBone Granules 1-3 mm; 5cc, GlassBone Granules 1-3 mm; 10cc, GlassBone Granules 0.5-1mm; 5cc and GlassBone Granules 1-3 mm; 16cc.